1.14
1.14 (0%)
As of Apr 17, 2025
Windtree Therapeutics Inc [WINT]
Source:
Company Overview
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases.
| Country | United States |
| Headquarters | warrington, pennsylvania |
| Phone Number | 2154889300 |
| Industry | manufacturing |
| CEO | Craig E. Fraser |
| Website | windtreetx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-26.1 |
| Net Income | $-1.8 |
| Net Cash | $-2.7 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -5.9% |
| Profit as % of Stockholder Equity | -17.9% |
Management Effectiveness
| Return on Equity | -17.9% |
| Return on Assets | -6.4% |
| Turnover Ratio | |
| EBITA | $-26.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $27.9 |
| Total Liabilities | $14.7 |
| Operating Cash Flow | $-15.4 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $12.7 |
